Invention Grant
US09125859B2 Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
有权
使用植物大麻素大麻素（CBDV）治疗癫痫
- Patent Title: Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
- Patent Title (中): 使用植物大麻素大麻素（CBDV）治疗癫痫
-
Application No.: US13075873Application Date: 2011-03-30
-
Publication No.: US09125859B2Publication Date: 2015-09-08
- Inventor: Ben Whalley , Claire Williams , Gary Stephens , Takashi Futamura
- Applicant: Ben Whalley , Claire Williams , Gary Stephens , Takashi Futamura
- Applicant Address: GB Cambridge JP Tokyo
- Assignee: GW Pharma Limited,Otsuka Pharmaceutical Co., Limited
- Current Assignee: GW Pharma Limited,Otsuka Pharmaceutical Co., Limited
- Current Assignee Address: GB Cambridge JP Tokyo
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: GB1005364.3 20100330; GB1100042.9 20110104
- Main IPC: A61K31/05
- IPC: A61K31/05 ; A61K31/19 ; A61K31/352 ; A61K31/40 ; A61K36/185 ; A61K45/06
Abstract:
This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital.
Public/Granted literature
- US20120004251A1 USE OF THE PHYTOCANNABINOID CANNABIDIVARIN (CBDV) IN THE TREATMENT OF EPILEPSY Public/Granted day:2012-01-05
Information query
